BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38873251)

  • 1. Prognostic models for colorectal cancer recurrence using carcinoembryonic antigen measurements.
    Mohammadian Rad N; Sosef O; Seegers J; Koolen LJER; Hoofwijk JJWA; Woodruff HC; Hoofwijk TAGM; Sosef M; Lambin P
    Front Oncol; 2024; 14():1368120. PubMed ID: 38873251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning for predicting colon cancer recurrence.
    Kayikcioglu E; Onder AH; Bacak B; Serel TA
    Surg Oncol; 2024 Jun; 54():102079. PubMed ID: 38688191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
    Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
    Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
    BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer.
    Zhou S; Sheng N; Ren J; He Q; Zhang Y; Gong J; Wang Z
    Front Oncol; 2021; 11():741309. PubMed ID: 34692522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting mortality and recurrence in colorectal cancer: Comparative assessment of predictive models.
    Alinia S; Asghari-Jafarabadi M; Mahmoudi L; Roshanaei G; Safari M
    Heliyon; 2024 Mar; 10(6):e27854. PubMed ID: 38515707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer.
    Uejima C; Saito H; Tada Y; Tanio A; Murakami Y; Yamamoto M; Matsunaga T; Fukumoto Y; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Fujiwara Y
    Yonago Acta Med; 2021 May; 64(2):176-183. PubMed ID: 34025192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III.
    Kim HS; Lee MR
    Ann Coloproctol; 2013 Aug; 29(4):155-9. PubMed ID: 24032116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexplained increases in serum carcinoembryonic antigen levels in colorectal cancer patients during the postoperative follow-up period: an analysis of its incidence and longitudinal pattern.
    Nozawa H; Yokota Y; Emoto S; Yokoyama Y; Sasaki K; Murono K; Abe S; Sonoda H; Shinagawa T; Ishihara S
    Ann Med; 2023; 55(2):2246997. PubMed ID: 37963211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carcinoembryonic antigen pre-operative level in colorectal cancer: revisiting risk stratification.
    Iacuzzo C; Germani P; Troian M; Cipolat Mis T; Giudici F; Osenda E; Bortul M; de Manzini N
    ANZ J Surg; 2021 Jun; 91(6):E367-E374. PubMed ID: 33870621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of a nomogram constructed from CEA, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer.
    Wang K; Ma L; Chen L; Jiang Y; Liu N; Cai J; Zhang Y
    Cancer Biomark; 2023; 38(4):537-549. PubMed ID: 37980649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.
    Ying HQ; Chen W; Xiong CF; Wang Y; Li XJ; Cheng XX
    Cancer Cell Int; 2022 Mar; 22(1):137. PubMed ID: 35346200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.